Indian pharma at the crossroads as US cracks the whip Companies rarely accept wrongdoing until they are presented with incontrovertible evidence
is executive editor at Mint and oversees the newsroom’s corporate coverage SUNDEEP KHANNA
There are very few industries as notorious as Big Pharma. Fewer still have done more to deserve that notoriety. Tweaking existing drugs to generate new patents, price gouging by creating artificial scarcities, and simply buying off competitors, there’s...
Read latest mint ePaper online.